Question 1

What is the magnitude of clinical inertia among asthma patients at Jimma Medical Center?

Accepted Answer

The magnitude of clinical inertia among adult asthma patients attending chronic follow-up at Jimma Medical Center was high, with approximately 68.9% of patients experiencing clinical inertia at the first visit and 70.4% at the second visit after three months. Clinical inertia includes failure to initiate or intensify inhaled corticosteroid (ICS) therapy as recommended by GINA 2021 guidelines, despite uncontrolled asthma symptoms.

Question 2

What factors contribute to clinical inertia among adult asthma patients at Jimma Medical Center?

Accepted Answer

Key factors associated with increased clinical inertia in this patient population include having allergic-related comorbidities (such as allergic rhinitis), longer asthma duration of 5 to 10 years since diagnosis, and having moderate or severe persistent asthma. Specifically, patients with moderate persistent asthma were about seven times more likely, and those with severe persistent asthma about ten times more likely, to experience clinical inertia compared to patients with mild persistent asthma.

Question 3

Is the asthma treatment at Jimma Medical Center aligned with global guidelines, and what are the issues observed?

Accepted Answer

Asthma management at Jimma Medical Center shows suboptimal adherence to guideline-recommended practices. About 35.6% of patients were not using inhaled corticosteroids (ICS) despite persistent symptoms, and only 5.2% received therapy intensification at each visit. Lack of medication intensification was reported in approximately half of the patients requiring it. These gaps are mostly due to healthcare infrastructure limitations, provider clinical inertia, and limited availability of combination therapies like ICS and LABA.

Question 4

How does asthma medication adherence and patient knowledge impact asthma control and clinical inertia at Jimma Medical Center?

Accepted Answer

Adherence to asthma medication was relatively low, with only 36.3% of patients categorized as adherent. About half of the patients had poor knowledge about asthma. Non-adherence to medication and poor asthma knowledge contribute to uncontrolled asthma and higher clinical inertia, as appropriate treatment initiation or intensification may be delayed or omitted.

Question 5

Are there specific challenges faced by adult asthma patients in Ethiopia that affect their treatment outcomes?

Accepted Answer

Yes, many patients face challenges such as limited access to appropriate and affordable medications, poor patient knowledge, and inadequate communication between physicians and patients. These factors contribute to the high burden of clinical inertia and uncontrolled asthma, leading to worsened outcomes, increased healthcare costs, and higher risks of hospitalization and death.

Question 6

Is Jimma Medical Center's asthma care beginner-friendly for newly diagnosed patients or those unfamiliar with asthma management?

Accepted Answer

This information is not publicly disclosed by the official source. However, the study indicates challenges in adherence to treatment guidelines and patient knowledge, suggesting that asthma care may require additional patient education and support to be fully beginner-friendly.

JMC Capital

Regulatory License

Account Information

Why Choose JMC Capital

Key Point 1

Key Point 2

Key Point 3

Key Point 4

Key Point 5

Key Point 6

Key Point 7

Advantages

Disadvantages

Broker Details

More Brokers

Resources

Legal

Support